MRC Equip 2026: Up to £1 Million for Mid-Range Biomedical Research Equipment in UKRI-Eligible Labs

MRC Equip 2026: Up to £1 Million for Mid-Range Biomedical Research Equipment in UKRI-Eligible Labs

The Medical Research Council’s MRC Equip call is a practical opportunity for research groups that need one serious piece of capital equipment to unlock or expand biomedical research. It is not a general lab-refresh fund and it is not a software development scheme. The official page is clear: the primary purpose of the equipment must be biomedical research, the request must be for a single piece of capital equipment, and the project has to fit the round’s demand-management rules.

That makes this opportunity useful for teams that already know exactly what is missing: a platform, instrument, or specialised system that will improve throughput, precision, or capability across a real user base. It is especially relevant if your current bottleneck is not ideas but hardware. If the right machine would let you do the science properly, this is the kind of call worth planning for now.

The opportunity is currently listed as a pre-announcement. The UKRI opportunity page shows an opening date of 13 August 2026 at 9:00am UK time and a closing date of 5 November 2026 at 4:00pm UK time. That gives applicants time to work with their research office, gather quotes, and make sure the proposed equipment is genuinely in scope before the round opens.

Key details

What MRC Equip is really for

MRC Equip sits in a useful middle zone. It is bigger than a modest consumables or maintenance request, but smaller and more targeted than a major facility award. The official guidance says the equipment must support biomedical research across MRC’s remit, and it can be either:

• new capability equipment, or
• replacement equipment for existing capability.

That second point matters. You do not need to pretend every request is about brand-new science. If a critical instrument is aging out, has become unreliable, or is preventing the group from doing modern work at the right quality, a replacement can still be a strong fit. The page even says second-hand or beta-testing equipment may be allowed if you can show how you are addressing the increased risk of failure.

What the call is not for is just as important:

• not very large facilities,
• not normal lab basics such as centrifuges, fridges, incubators, or generic storage,
• not buildings or general infrastructure,
• not a generic department-wide computing platform,
• not software development,
• and not equipment whose main purpose lies outside biomedical research.

If your request starts sounding like “the whole department needs everything” rather than “this specific platform will unlock this biomedical programme,” you are probably drifting out of scope.

Who should consider applying

This is a strong opportunity for a narrow but important audience: researchers and research technical professionals who can make a convincing case that one piece of equipment will materially improve biomedical output.

The page explicitly encourages applications from research technical professionals as project lead or project co-lead. That is a useful signal. These calls are often strongest when the technical person closest to the equipment is central to the application, because they understand use, maintenance, scheduling, and likely failure points better than anyone else.

You are likely a good fit if:

• your group already has biomedical projects ready to use the equipment,
• the equipment will support multiple users or a clearly justified programme of work,
• your institution can host the hardware properly,
• and your case can show that the equipment is not a speculative wish list item.

The opportunity is open to applicants at eligible UK research organisations, and the page says applicants based within MRC institutes and units, including the MRC Unit The Gambia and the MRC/UVRI and LSHTM Uganda Research Unit, are eligible as project lead. International research organisations are not eligible except for those specific MRC units.

The page also applies demand management. A research organisation may submit up to two applications per round, and a person may be project lead on only one application in that round unless MRC agrees otherwise. That makes internal coordination important. If your institution has several competing hardware priorities, you should sort them early rather than find out too late that two stronger proposals have cannibalised one another.

What you can request and what you need to prove

MRC says the request may cover capital equipment costs over £200,000 including VAT, and the FEC can be up to £1 million. The funder will cover 100% of FEC.

That sounds generous, but the real test is justification. The panel will expect you to explain:

1. Why this exact piece of equipment is needed now.
2. Why existing kit is not enough.
3. Who will use it.
4. What biomedical research it will enable.
5. Why the price is realistic.

The page says you should obtain quotes from multiple suppliers where possible and avoid using list prices if discounts are usually available. That is an important practical note. A credible budget is not simply “the equipment is expensive”; it is “we obtained market-based pricing and this cost reflects real procurement conditions.”

You can also include installation or service maintenance costs if they are one-off and part of the manufacturer’s offer. Service contracts of up to five years may be included. That makes sense for expensive equipment where uptime matters and the total cost of ownership is part of the case.

If the proposal involves a multi-component platform, MRC wants a single technology platform rather than several unrelated purchases. If you think your package could be interpreted as several components, the page says you should contact MRC first with a short one-page outline before submission. That is the kind of early clarification that can save you from an avoidable scope rejection.

How the application process works

The page says the opportunity will run on the UKRI Funding Service, and that full details on how to apply will be published when the funding opportunity opens. So the current round is best treated as a planning window.

At the moment, the practical process looks like this:

1. Check whether your organisation is eligible for MRC funding.
2. Confirm that the proposed equipment is biomedical research equipment and that it falls within the capital threshold.
3. Gather supplier quotes and confirm installation or maintenance assumptions.
4. Decide whether the request is for new capability or replacement capability.
5. Confirm that your proposal can finish by the expected end date of 31 December 2027.
6. Make sure your institution is prepared for the demand-management limit of two applications per research organisation.

Because the call is a pre-announcement, some form fields and exact submission requirements may still change. That means you should avoid treating the current page as a final application instruction sheet. Treat it as a design brief: you know the budget band, the eligibility framework, the scope, and the likely timing, so you can prepare a strong package before the live round begins.

A sensible preparation timeline

The best use of the months before opening is to remove uncertainty.

Now: decide whether the equipment is truly a single capital item with a biomedical purpose. If the answer is fuzzy, the application is probably not ready.

Before August 2026: secure user demand. If multiple labs will use the equipment, write down who they are, what they will do, and how the instrument will be scheduled or governed. Equipment calls tend to reward a credible access model, not just a wish list.

Before September 2026: gather quotations and service information. If the equipment has major installation needs, site requirements, or specialist maintenance, document that early.

Before the November deadline: align with your research office, confirm internal approvals, and make sure the narrative explains value for biomedical research rather than general convenience.

Before the planned June 2027 start date: make sure procurement, room preparation, IT, safety, and staffing are actually feasible. A brilliant application can still stumble if the institution cannot deliver the hardware on time.

That timeline matters because this type of award is as much about execution as it is about scientific need. A panel wants confidence that the equipment can arrive, be installed, be used, and produce output within the award window.

What makes a strong case

Strong equipment applications usually do three things well.

First, they show clear scientific dependency. The project or programme should visibly rely on the equipment. If the science could continue unchanged without it, the case is weak.

Second, they show shared value. A single machine can still be justified by one group, but it is often stronger when the equipment serves more than one project or user group and clearly improves capability across the host organisation.

Third, they show credible operational planning. Reviewers do not only care about the science. They care whether the equipment can be housed, maintained, insured, supported, and used at the right level of uptime.

If you are using replacement equipment, the best cases explain what additional capability the new model adds. Maybe it is higher resolution, better automation, lower failure risk, improved speed, or a function that the old instrument never had. Do not rely on “ours is broken” alone. Show why the replacement changes research outcomes.

Common mistakes to avoid

The most common mistake is treating this as a generic capital request. It is not. The page is explicit about biomedical research scope, and anything too broad will weaken fast.

Other mistakes include:

• asking for multiple unrelated items as if they were one platform,
• forgetting the £200,000 threshold,
• assuming list prices are acceptable without checking supplier quotes,
• requesting generic lab equipment that the page excludes,
• and under-explaining who will use the equipment once it arrives.

Another problem is timing. The deadline may be fixed, but if your institution has to approve the project, secure quotes, and validate the room or maintenance plan, the real deadline is earlier. Missing internal lead time is a common failure mode for equipment calls.

Frequently asked questions

Is this for software or digital tools?

No. The page excludes software-package development and generic computing platforms. The focus is capital equipment for biomedical research.

Can I apply for a replacement instrument?

Yes. The page explicitly allows replacement equipment if you explain the new capacity or capability it provides.

Can I request second-hand equipment?

Yes, or beta-testing equipment, if you address the associated risks and likelihood of failure.

How long can the project run?

Up to seven months, with an expected end date of 31 December 2027.

Is there a funding cap?

Yes. The FEC can be up to £1 million, and MRC funds 100% of FEC.

Can every UK institution submit as many applications as it wants?

No. The round is demand-managed. A research organisation is limited to two applications per round unless MRC says otherwise.

Official links

• Official MRC Equip page: https://www.ukri.org/opportunity/purchase-mid-range-equipment-for-biomedical-research-mrc-equip/
• MRC eligibility guidance: https://www.ukri.org/councils/mrc/guidance-for-applicants/check-if-you-are-eligible-for-funding/1-1-types-of-research-organisations/
• UKRI Funding Service: https://www.ukri.org/

If your lab is waiting on a single major instrument to unlock a biomedical programme, this is the sort of call that deserves immediate attention. It is tightly scoped, but that is exactly why it can be persuasive: a specific piece of equipment, a specific research need, and a specific route to stronger biomedical capability.